CN1081897A - Musk naotongsu - Google Patents
Musk naotongsu Download PDFInfo
- Publication number
- CN1081897A CN1081897A CN 93104972 CN93104972A CN1081897A CN 1081897 A CN1081897 A CN 1081897A CN 93104972 CN93104972 CN 93104972 CN 93104972 A CN93104972 A CN 93104972A CN 1081897 A CN1081897 A CN 1081897A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- cerebral
- musk
- naotongsu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000402754 Erythranthe moschata Species 0.000 title claims abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 14
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 7
- 208000026106 cerebrovascular disease Diseases 0.000 claims abstract description 6
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 4
- 241001161070 Calomela Species 0.000 claims abstract description 4
- 241000628997 Flos Species 0.000 claims abstract description 4
- 239000004863 Frankincense Substances 0.000 claims abstract description 4
- 241001057584 Myrrha Species 0.000 claims abstract description 4
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 4
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 4
- 239000009286 sanguis draxonis Substances 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims abstract description 4
- 241001250596 Pleione Species 0.000 claims abstract description 3
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 3
- 241000411851 herbal medicine Species 0.000 claims description 8
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000003672 processing method Methods 0.000 claims description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 2
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 2
- 244000082204 Phyllostachys viridis Species 0.000 claims description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 2
- 239000011425 bamboo Substances 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000004383 yellowing Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 1
- 208000024806 Brain atrophy Diseases 0.000 abstract description 4
- 208000003906 hydrocephalus Diseases 0.000 abstract description 4
- 208000007333 Brain Concussion Diseases 0.000 abstract description 3
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 abstract description 3
- 206010008132 Cerebral thrombosis Diseases 0.000 abstract description 3
- 201000001429 Intracranial Thrombosis Diseases 0.000 abstract description 3
- 206010008118 cerebral infarction Diseases 0.000 abstract description 3
- 201000005851 intracranial arteriosclerosis Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 241001489978 Eupolyphaga Species 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000972155 Moschus Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 231100000167 toxic agent Toxicity 0.000 abstract 1
- 239000003440 toxic substance Substances 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 240000007695 Nandina domestica Species 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention belongs to a Chinese medicine musk naotong extract for curing cerebrovascular disease. The main formula components of the medicine are as follows: sanguis Draxonis, Notoginseng radix, Eupolyphaga Seu Steleophaga, concretio silicea Bambusae seu schizostachyi, herba Artemisiae Anomalae, Galla chinensis, Carthami flos, Calomelas, Moschus, radix et rhizoma Rhei, radix Angelicae sinensis, medulla Junci, Olibanum, Myrrha, semen Flemingiae Philippinensis, Pyritum, Realgar, and Pseudobulbus Cremastrae seu pleiones. The main treatment is as follows: promoting blood circulation for removing blood stasis, relieving inflammation, removing toxic substance, and relieving pain, and can be used for treating brain atrophy, hydrocephalus, craniocerebral hypertension, cerebral concussion sequelae, cerebral thrombosis, cerebral infarction, and cerebral arteriosclerosis. Has the advantages of high cure rate, quick response, money saving, convenient administration, safety, reliability, no side effect and the like.
Description
The invention belongs to a kind of Chinese medicine medicine " musk naotongsu " with Chinese herbal medicine formula processing and fabricating treatment cerebrovascular disease.
At present, China to treatment brain atrophy, hydrocephalus, set out that cerebral increases, cerebral concussion sequela, cerebral thrombosis, cerebral infarction, cerebral arteriosclerosis, do not have what good cure method, as hydrocephalus, operation back mortality rate is higher, and sequela is also bigger, brain atrophy also can only be that DeGrain is maintained the statusquo in medication.
Purpose of the present invention is exactly at the Chinese medicine medicine " musk naotongsu " of above-mentioned disease with the Chinese herbal medicine formula processing and fabricating.It is very remarkable to take the back effect, and it is high and leave problem such as sequela to have solved the postoperative death rate.
The object of the present invention is achieved like this: " musk naotongsu " Main Ingredients and Appearance prescription is by Sanguis Draxonis 15g, Radix Notoginseng 15g, eupolyphage sece steleophaga 25g, Concretio silicea Bambusae seu schizostachyi 10g, Herba Artemisiae Anomalae 10g, Galla Chinensis 10g, Flos Carthami 10g, Calomelas 0.2g, Moschus 0.1g, Radix Et Rhizoma Rhei 15g, Radix Angelicae Sinensis 10g, Medulla Junci 5g, Olibanum 10g, Myrrha 10g, Semen Euphorbiae 5g, Pyritum 15g, Realgar 15g, Pseudobulbus Cremastrae seu Pleiones 10g processes formulated.Its processing method be said herbal medicine clean, screening, part medicine (Radix Et Rhizoma Rhei, Realgar, Pyritum) processing back and other medicines are ground into fine powder jointly, incapsulate after mixing all.
" musk naotongsu " of the present invention cures mainly: phlegm reduction of blood circulation promoting, antiinflammatory, detoxifcation, pain relieving, can treat brain atrophy, hydrocephalus, set out that cerebral increases, cerebral concussion sequela, cerebral thrombosis, cerebral infarction, cerebral arteriosclerosis.Have the cure rate height, instant effect, the province that spends, take medicine convenient and safe reliably, advantage such as have no side effect.
Be most preferred embodiment of the present invention below: " musk naotongsu " Main Ingredients and Appearance prescription is by Sanguis Draxonis 15g, Radix Notoginseng 15g, eupolyphage sece steleophaga 25g, nandina spring 10g, Herba Artemisiae Anomalae 10g, Galla Chinensis 10g, Flos Carthami 10g, Calomelas 0.2g, Moschus 0.1g, Radix Et Rhizoma Rhei 15g, Radix Angelicae Sinensis 10g, Medulla Junci 5g, Olibanum 10g, Myrrha 10g, Semen Euphorbiae 5g, Pyritum 15g, Realgar 15g, it is formulated that the mountain thatch eats 10g processing.Its processing method is that said herbal medicine is cleaned, screened, with part medicine (Radix Et Rhizoma Rhei 15g, Realgar 15g, Pyritum 15g), fry with pot, behind the yellowing and other said herbal medicine pulverize jointly, sieve into fine powder, incapsulate after stirring and get final product with 120 order square-bottomed bamboo baskets.
Claims (2)
1, the invention belongs to a kind of Chinese medicine medicine " musk naotongsu " with Chinese herbal medicine formula processing and fabricating treatment cerebrovascular disease, it is characterized in that: its composition of mainly filling a prescription is by Sanguis Draxonis 15g, Radix Notoginseng 15g, eupolyphage sece steleophaga 25g, Concretio silicea Bambusae seu schizostachyi 10g, Herba Artemisiae Anomalae 10g, Galla Chinensis 10g, Flos Carthami 10g, Calomelas 0.2g, Moschus 0.1g, Radix Et Rhizoma Rhei 15g, Radix Angelicae Sinensis 10g, Medulla Junci 5g, Olibanum 10g, Myrrha 10g, Semen Euphorbiae 5g, Pyritum 15g, Realgar 15g, Pseudobulbus Cremastrae seu Pleiones 10g processing is formulated.
2, also be according to its feature of the described " musk naotongsu " of claim (1): its processing method be said herbal medicine clean, screening, part medicine (Radix Et Rhizoma Rhei 15g, Realgar 15g, Pyritum 15g), fry with pot, behind the yellowing, pulverize jointly with other said herbal medicine, sieve into fine powder, incapsulate after stirring with 120 order square-bottomed bamboo baskets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93104972 CN1081897A (en) | 1993-04-24 | 1993-04-24 | Musk naotongsu |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93104972 CN1081897A (en) | 1993-04-24 | 1993-04-24 | Musk naotongsu |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1081897A true CN1081897A (en) | 1994-02-16 |
Family
ID=4985489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93104972 Pending CN1081897A (en) | 1993-04-24 | 1993-04-24 | Musk naotongsu |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1081897A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059805C (en) * | 1995-08-07 | 2000-12-27 | 杨旭义 | Capsule for cerebral arteriosclerosis |
| CN1066959C (en) * | 1998-11-27 | 2001-06-13 | 宋虎杰 | Medicine for treating hydrocephalus |
| CN1067891C (en) * | 1997-05-08 | 2001-07-04 | 曾力群 | Pure Chinese drug for curing cerebral thrambus |
| CN100341549C (en) * | 2004-12-07 | 2007-10-10 | 云南龙升医药科技有限公司 | Medicinal preparation for treating or preventing beart brain blood vessel diseases |
| CN104547611A (en) * | 2014-12-29 | 2015-04-29 | 徐新建 | Medicine for treating encephalatrophy and preparation method of medicine |
| CN103933290B (en) * | 2014-05-07 | 2017-03-08 | 合肥华方医药科技有限公司 | Chinese medicine composition for the treatment of craniocerebral injury syndrome and preparation method thereof |
-
1993
- 1993-04-24 CN CN 93104972 patent/CN1081897A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059805C (en) * | 1995-08-07 | 2000-12-27 | 杨旭义 | Capsule for cerebral arteriosclerosis |
| CN1067891C (en) * | 1997-05-08 | 2001-07-04 | 曾力群 | Pure Chinese drug for curing cerebral thrambus |
| CN1066959C (en) * | 1998-11-27 | 2001-06-13 | 宋虎杰 | Medicine for treating hydrocephalus |
| CN100341549C (en) * | 2004-12-07 | 2007-10-10 | 云南龙升医药科技有限公司 | Medicinal preparation for treating or preventing beart brain blood vessel diseases |
| CN103933290B (en) * | 2014-05-07 | 2017-03-08 | 合肥华方医药科技有限公司 | Chinese medicine composition for the treatment of craniocerebral injury syndrome and preparation method thereof |
| CN104547611A (en) * | 2014-12-29 | 2015-04-29 | 徐新建 | Medicine for treating encephalatrophy and preparation method of medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101987123B (en) | Medicament for easing pain of human body and preparation method thereof | |
| CN1224614A (en) | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation | |
| AU2002349482A1 (en) | A medicine for treating woman climacteric syndrome and preparation method thereof | |
| CN103316192B (en) | Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof | |
| CN101357201A (en) | Multipurpose traditional Chinese medicine and preparation method thereof | |
| CN1081897A (en) | Musk naotongsu | |
| CN1046856C (en) | Method for prepn. of bolus with function of invigorating brain and tonifying kidney | |
| CN101391044A (en) | External traditional Chinese medicine for treating zoster, herpes simplex or the other viral disease and preparation method thereof | |
| CN1164284C (en) | Medicine for treating neonatal jaundice | |
| CN1823925A (en) | New preparation for treating constrained liver qi | |
| CN105832939A (en) | Compound herb plant medicament for treating porcine diarrhea and preparation method thereof | |
| CN105995191A (en) | Chinese herbal medicine additive for health restoration of grass carp parent fish after spawning induction | |
| CN1689612B (en) | Liver disease treating particle and its production method | |
| CN101278982A (en) | Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same | |
| CN1212885A (en) | Traditional Chinese medicine capsule for treating thrombophlebitis | |
| CN101028319B (en) | Chinese-medicine compound preparation against coronary heart disease and its production | |
| CN1116892C (en) | Bagged blood circulation-activating and obstruction-dredging granule and its preparation | |
| CN1418701A (en) | Bushenshansong drink and preparation method thereof | |
| CN1164318C (en) | Capsule for treating gynaecological inflammation | |
| CN1823981A (en) | New preparation for treating obesity | |
| CN1051934C (en) | Xiansukang capsule for curing epilepsy and its production | |
| CN101352529A (en) | Chinese medicine preparation for quickly treating headache | |
| CN101194963B (en) | Process for preparing medicine for treating headache | |
| CN105641168A (en) | Medicine for treating viral hepatitis B and viral hepatitis C and preparation method of medicine | |
| CN101317936A (en) | Method for preparing capsule for reliving liver and reliving upset |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |